 CNBCs Meg Tirrell talks to Ivan Cheung, Eisai U.S. CEO on the companys Alzheimers drug receiving approval from the FDA today. With CNBCs Tyler Mathisen and the Fast Money traders, Tim Seymour, Bonawyn Eison, Steve Grasso and Jeff Mills. 